Tag | Content |
---|
EnhancerAtlas ID | HS034-28344 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr7:101928960-101931370 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF16 | MA0741.1 | chr7:101930020-101930031 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930056-101930067 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930081-101930092 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930111-101930122 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101929568-101929579 | GGGGGCGTGGT | - | 6.14 | KLF5 | MA0599.1 | chr7:101930021-101930031 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930057-101930067 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930082-101930092 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930112-101930122 | GGGGCGGGGC | - | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | - | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | - | 6.02 | SP1 | MA0079.4 | chr7:101930019-101930034 | CGGGGGCGGGGCCTG | - | 6.11 | SP1 | MA0079.4 | chr7:101930055-101930070 | AGGGGGCGGGGCCAG | - | 6.57 | SP2 | MA0516.2 | chr7:101930054-101930071 | GAGGGGGCGGGGCCAGG | - | 6.09 | SP3 | MA0746.2 | chr7:101930080-101930093 | GGGGGGCGGGGCC | - | 6.11 | SP3 | MA0746.2 | chr7:101929567-101929580 | AGGGGGCGTGGTG | - | 6.29 | SP4 | MA0685.1 | chr7:101930053-101930070 | GGAGGGGGCGGGGCCAG | - | 7.25 | SP8 | MA0747.1 | chr7:101929567-101929579 | AGGGGGCGTGGT | - | 6.52 | Zfx | MA0146.2 | chr7:101930020-101930034 | GGGGGCGGGGCCTG | + | 6.19 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_58693 | chr7:101922324-101974102 | Ly1 | SE_60412 | chr7:101921972-101976670 | DHL6 | SE_61924 | chr7:101916815-101972690 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr7 | 101929153 | 101929600 | chr7 | 101929978 | 101930313 | chr7 | 101929501 | 101929660 |
|
Enhancer Sequence | TTAGAGATGG GAAATGGCTC TGGGAAAAGT CAGAGGTCAG TTTGGGCCCG GGAGGGCGAC 60 AGATGGAGGC AGCTCCGGCT GGCAAGGAGA CCAGGACAGA ACTGCCAGAG GTGGGGGCAG 120 GGGACAAGGA GGGAGATGAG GGGAGAAGAC ACCCAGGGGT CCCCCCCTGC TATCTCCAGG 180 AGCAAGACTA CTCTCTTCTC TGAGCGGCCC TTTCCACACC TCTGCCCCCA CCGAAGCCCT 240 CCCTCCCCTC TCAGACCCCT TCCAGGCCTG CTGAGCCCCC TGCACCTCTT TCAGGAAGCC 300 TCCCAGAGCC CCCGCGCCGT GCCCTCAGCA CCAGGGGTCA GGCTACAAAT GCCCCGCAAA 360 GCCCAGCGGG ACTGTTTCCT CAGCCCCACT GGTCTCTGCC CTAAAGCAGG CGAGTTCTGG 420 AGCCAGGCAG GGGTGAGGAA GGTGCCAGGG TTGTGGCCCC TCATCGCCCC TCTATGATCT 480 CTGACACCTC TCCGGGTGGC ATCAGGCCCC CATCACAGCG AAGGCTGGGT GGTGGGGGCA 540 CTGCGCTCAG GGGGGCCGTC CCGCCCTGTG GCCCGGGGGC GATTTCCCGC ACCGGAGGGC 600 TGCAGGGAGG GGGCGTGGTG GCGCCCTCGA GATTTATGAG AACCAGGCGT CGACTTCCTC 660 CGTTGCGACA TCCAGGCCTC CTCCAGGCTC CCATTGTCCC TGCTGCGGAG AGTCTGGCCA 720 CAGCGGCGGC TCCCGCGAAG CACCCGTCAG CGAGGGGCGC TTCGAGGGCG TCCGCGTCCC 780 ATACACCCGC CACGCAGGAC ATTCCCCCGG CCCCACGCTC CGCGCTCCCG GGGCCACCAC 840 CACCGCGGGC TCGAGGGGTG GCCTCCACGA GGAGGAGTGG GAGTCCCGCG CCTGGCCTGG 900 GGCCGGCTCG GCGACATGGG GACCCCCGCC CAGATGGGGC GACTCGGAGC CGGCTCCTAA 960 CCCCTCTCTC CGGGCCCCAG GACCGGGCAG TCTCGGCACC GCAGCTGCGG GGAGCCAGCA 1020 AGCACCGGCC ACCGGCGCCG CTCGGGCTCC GCGGATGGCC GGGGGCGGGG CCTGAGCGGC 1080 GCAAGTGGGG GCGGGAGGGG GCGGGGCCAG GACGCGCGAG GGGGGGCGGG GCCGGGGCTC 1140 GCGGCGGGGG CGGGGGCGGG GCCGGGGCCG GGAGGCGCGC GCCTCGCGGG CGGGGGGCGC 1200 GCCGCGCTGG GCTGGGCTTG GAGCGCGCGG AGCTCGGCTG CCAGAGAGCC GCGCGGGGGA 1260 CGCGCCGGGA CCGCGAGGAG CGCAGGAGCC TTCGAGGCGG TGAACGAGGG AGGGAGCCCA 1320 GTCCGCCGCG GGCCATGAGC CACCGGGCCC GGGGAGCCCG GCCGCGGTCC GGGCAGCGCT 1380 CAGCCGGCGC CCCAGCCCGC TCGGCCGCAG CTGCGCGCCT GTAGGTATGG CCTCCTTATA 1440 CCCAGTTCCT CGCTCCCTGG TCCTTCCCCC GGGACCCCTG TCTGTCCCCG GGGACGTGCG 1500 CTGTGTGCGC ACCGCTGCCC GAAGGAGAGC GGCCGCACGC GCCTTGGTCC GCGCGTGTCG 1560 TCTTTGTGTG CGCGGGTGGG AGGGAGGAGG GCGCGCGAGG GAGGGGAGGC GCCCCCGGCT 1620 GGGATCTGCT CCCCGATCCC CATCCCGGGC GGGGCGGGGA GCCGCTGGAG GGGCCGAGCC 1680 GCCTCTGGAG CAGCTGCGCC CCCGCCCCCT GCTAGGGCCC CGGCCGGGTA GTGGGGCGAG 1740 AGCAGCCGGG TCCTTAGAGG AGGGGTCTCT GGTTGGGGGA AGGGGTGCCC AGGTCTCTTC 1800 CCTACGCTGG GAGCGCTGGG AGGGGGCGTC AACCTAGAAT GAGGGTGAGG GCCACGGGAT 1860 GGGATCGGGG AGGACCTCCT CCAGGCCACA GGCACGCCCT CCCTTTGGCC CAGGCCCCCC 1920 TTTCTCGACC TGCCCAGCCG GGGAGCTCCC CGGAGCCCCC GATTGCCGGG AGGATCGTGG 1980 AGGGTGCCCA AGAGGCCGGC GCCTTTAAGA AGGGGCGGGT TCGTGCCCTC CATTCAGGCC 2040 CTTGGGCCTC GGCCATTGAT GAACCTGCGG GCTGCGCGGG CCGGAACCGC GCCAGCCCAG 2100 CGGGCTGAAG CCGGGCAGAG GCAGGGACGC ATCCTGGCCC CCTGCAGCCC CGAAGTGGGG 2160 GCCTTCAGGG AGGGAAGTCT GCAGTGACTG GAGCCTCTCA GGAGCCACGC AAGGCAGACC 2220 GGGCAGCCCC AGGCGAGACT CTGAACACGA ATAAGCCAGG ATCTACGTGC ACTTCGAGCT 2280 AGTGCAAGGG AGAGCCTCAG GCTAGGCTGT CAGACCTGGG TGGAGCCCTA CCAATGCCCC 2340 CGAGCCAACA TCACCTACCC TGTAAAATGG GATGGTGCTG CCTGCCTCCT GGCTAAGGGA 2400 CCGGCAACTC 2410
|